Pharmacological modulators of DNA-interactive antitumor drugs
- 1 September 1989
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (9) , 369-373
- https://doi.org/10.1016/0165-6147(89)90010-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- DNA as a target for drug actionTrends in Pharmacological Sciences, 1988
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988
- Specific Reduction of Toxic Side Effects of Adriamycin by Induction of Metallothionein in MiceJapanese Journal of Cancer Research, 1988
- Resistance to multiple chemotherapeutic agents in human cancer cellsTrends in Pharmacological Sciences, 1988
- METALLOTHIONEINAnnual Review of Biochemistry, 1986
- Binding of cis-dichlorodiammine platinum(II) to metallothionein in Ehrlich cellsBiochemical and Biophysical Research Communications, 1985
- Genetic and biochemical characterization of multidrug resistancePharmacology & Therapeutics, 1985
- Glutathione-conferred resistance to antineoplastics: Approaches toward its reductionCancer Treatment Reviews, 1984
- Reduction in cellular glutathione by buthionine sulfbximine and sensitization of murine tumor cells resistant to L-phenylalanine mustardBiochemical Pharmacology, 1984
- Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothioneinToxicology and Applied Pharmacology, 1981